Boiron SA (EPA:BOI)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacture and Marketing of Homeopathic Medicines & Other Healthcare Solutions	501.11M	487.56M	493.25M	534.24M	455.20M
Manufacture and Marketing of Homeopathic Medicines & Other Healthcare Solutions Growth	2.78%	-1.15%	-7.67%	17.36%	-11.37%
Total	501.11M	487.56M	493.25M	534.24M	455.20M
Total Growth	2.78%	-1.15%	-7.67%	17.36%	-11.37%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
France	344.43M	340.80M	342.28M	394.69M	327.00M
France Growth	1.07%	-0.43%	-13.28%	20.70%	-21.16%
Europe (excluding France)	120.97M	123.88M	122.77M	126.31M	111.55M
Europe (excluding France) Growth	-2.35%	0.90%	-2.80%	13.23%	1.32%
North America	138.19M	126.45M	120.51M	120.70M	83.91M
North America Growth	9.29%	4.93%	-0.16%	43.83%	-16.74%
Other Countries	27.24M	21.97M	16.28M	15.12M	10.20M
Other Countries Growth	23.98%	35.01%	7.63%	48.32%	29.64%
Eliminations	-129.73M	-125.53M	-108.58M	-122.58M	-77.46M
Total	501.11M	487.56M	493.25M	534.24M	455.20M
Total Growth	2.78%	-1.15%	-7.67%	17.36%	-11.37%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 19, 2026

Data Sources Report a data error